Purpose To improve on current standards for breast cancer prognosis and prediction of
chemotherapy benefit by developing a risk model that incorporates the gene expression–based “…

Motivation: Systematic differences due to experimental features of microarray experiments
are present in most large microarray data sets. Many different experimental features can …

Characteristic patterns of gene expression measured by DNA microarrays have been used
to classify tumors into clinically relevant subgroups. In this study, we have refined the …

Background Gene expression profiling of breast cancer has identified two biologically
distinct estrogen receptor (ER)-positive subtypes of breast cancer: luminal A and luminal B. …

Introduction In breast cancer, gene expression analyses have defined five tumor subtypes (luminal
A, luminal B, HER2-enriched, basal-like and claudin-low), each of which has unique …

Background Titanium dioxide is a widely used nanomaterial whose photo-reactivity suggests
that it could damage biological targets (eg, brain) through oxidative stress (OS). Objectives …

We performed an extensive immunogenomic analysis of more than 10,000 tumors comprising
33 diverse cancer types by utilizing data compiled by TCGA. Across cancer types, we …

MicroRNAs are short, noncoding RNA transcripts that post-transcriptionally regulate gene
expression. Several hundred microRNA genes have been identified in Caenorhabditis elegans…

Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Here, we
describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic …

For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic
annotation data along with multi-platform molecular profiles of more than 11,000 human tumors …